Qiming Venture Partners Portfolio Companies Shine on 2025 China Globalization Rising Stars 100 List
The ranking focuses on companies that achieved at least $10 million in overseas revenue in 2024, as well as companies that have already generated overseas revenue to date and possess strategic deployment capabilities in the global market.
Recently, Cyzone released its 2024 China Globalization New Forces Top 100 list, spotlighting pioneering enterprises that are leading their industries and making waves on the global stage.
The list is divided into two categories: established leaders and high-growth companies. Established leaders achieved at least $10 million in overseas revenue in 2024; high-growth companies have already generated international revenue and demonstrate forward-looking strategic capabilities in global markets.
Qiming Venture Partners portfolio companies Abbisko Therapeutics (02256.HK), PETKIT, Zuzuche, and APUS were named to the Established Leaders list; WeRide (NASDAQ:WRD), DeepWay, Transwarp Technology (688031.SH), Tetramer, Yimai Gongpin, and ACX Instruments were named to the High-Growth Companies list.
Abbisko Therapeutics
(Biotech)
PETKIT
(Consumer goods)
Zuzuche
(Travel and mobility)
APUS
(AI)
Named to the
2024 China Globalization New Forces Top 100 — Established Leaders
WeRide, DeepWay
(Automotive)
Transwarp Technology, Tetramer
(AI)
Yimai Gongpin
(E-commerce)
ACX Instruments
(Biotech)
Named to the
2024 China Globalization New Forces Top 100 — High-Growth Companies
· 2024 China Globalization New Forces Top 100
The selection process combined research follow-ups with expert panel reviews. After verifying data, conducting analysis, and performing due diligence on applicant companies, Cyzone finalized the list based on operational metrics, financial performance, local market presence, and global influence.
Cyzone found that nearly one-quarter of listed companies were founded in 2021 or later; nearly two-thirds launched their overseas expansion in 2021 or later. These companies chose to venture abroad during a period of rapid technological change and volatile market conditions — they carry innovation in their DNA, keenly perceive and seize latent demand and opportunities in global markets, and are distinguishing themselves worldwide through innovative products, technologies, and business models as representatives of China's new globalization forces.
By sector, intelligent manufacturing and AI companies dominated the list, followed by consumer goods, biotech, automotive, and new energy.
In AI, Chinese companies are reshaping global industrial structures through large language models, agents, digital humans, and distributed platforms. Meanwhile, AI technology, industrial LLMs, and intelligent agents have become core drivers of "digital-intelligent globalization" for Chinese manufacturers, with diverse scenarios showcasing the global competitiveness of "Created in China." In intelligent manufacturing, "intelligent robots" have emerged as a critical delivery mechanism for Chinese smart manufacturing companies in global markets, with domestic robots holding advantages in technological innovation, supply chain integration, and cost control.
Source | Cyzone
Past Coverage
Qiming Stars | Four Qiming Venture Partners portfolio companies named to Cyzone 2024 Hard Tech Disruptors 50 Qiming Honors | Qiming Venture Partners' Duane Kuang, William Hu, and Alex Zhou named to PEDaily 2025 Top 100 Investors Qiming Stars | Multiple Qiming Venture Partners portfolio companies featured at 2025 Summer Davos
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management of $9.5 billion. Since inception, the firm has focused on investing in outstanding early- and growth-stage companies in Technology and Healthcare.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative enterprises, with more than 210 listed on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many Qiming Venture Partners portfolio companies have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Insta360 (688775.SH), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), Sinocelltech (688520.SH), Yuanxin Technology, Insilico Medicine, MediLink Therapeutics, LaNova Medicines, Zhipu AI, StepFun, Biren Technology, and others.